Her2-neu score as a prognostic factor for outcome in patients with triple-negative breast cancer.
Schmidt G, Gerlinger C, Juhasz-Böss I, Stickeler E, Rody A, Liedtke C, Wimberger P, Link T, Müller E, Fehm T, Abel M, Stein S, Bohle R, Endrikat J, Solomayer EF.
Schmidt G, et al. Among authors: solomayer ef.
J Cancer Res Clin Oncol. 2016 Jun;142(6):1369-76. doi: 10.1007/s00432-016-2146-z. Epub 2016 Mar 23.
J Cancer Res Clin Oncol. 2016.
PMID: 27008006